title: Inhalation anesthesia with sevoflurane during intravitreal bevacizumab injection in infants with retinopathy of prematurity.
abstract: BACKGROUND
  To investigate the anesthetic management in premature infants with retinopathy of prematurity (ROP) treated with intravitreal bevacizumab (IVB) injections.
  
  
  METHODS
  A retrospective chart review was performed for the patients with ROP who had IVB injection. Clinical characteristics, demographic variables, anesthetic medications, operation techniques, time intervals, and complications were recorded.
  
  
  RESULTS
  Sixty-six eyes of 33 patients (23 males, 10 females) with type 1 ROP who were treated with IVB were included. A total of 66 anesthetic applications were performed. Mean gestational age at birth was 28.3 weeks (range 25-33). Mean birth weight was 1,300 g (range 600-1850). Serious ocular and systemic complications were not observed in any infant.
  
  
  CONCLUSIONS
  Inhalation anesthesia with sevoflurane during IVB treatment in premature infants with ROP may be appropriate for anesthetic management.
authors.affiliation: Department of Anesthesiology, Faculty of Medicine, Dicle University, 21280 Diyarbakır, Turkey. orhantokgoz58@gmail.com
authors.forename: Orhan
authors.initials: O
authors.lastname: Tokgöz
authors.forename: Alparslan
authors.initials: A
authors.lastname: Sahin
authors.forename: Adnan
authors.initials: A
authors.lastname: Tüfek
authors.forename: Yasin
authors.initials: Y
authors.lastname: Cınar
authors.forename: Abdülmenap
authors.initials: A
authors.lastname: Güzel
authors.forename: Taner
authors.initials: T
authors.lastname: Ciftçi
authors.forename: Feyzi
authors.initials: F
authors.lastname: Celik
authors.forename: Harun
authors.initials: H
authors.lastname: Yüksel
mesh_terms: D000758:Anesthesia; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D001239:Inhalation; D058449:Intravitreal Injections; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage*; D011247:Pregnancy; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000473:pathology; D000077149:Sevoflurane
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D008738:Methyl Ethers; D000068258:Bevacizumab; D000077149:Sevoflurane